三生製藥(01530.HK)與TMF(Cayman) Ltd.同意授出的購股權將無償註銷
格隆匯5月10日丨三生製藥(01530.HK)公吿,在公司董事會批准(包括獨立非執行董事的批准)下,公司與TMF(Cayman) Ltd.已同意授出的購股權將按照購股權計劃的條款無償註銷,自本公吿日期起生效。
購股權計劃的目的(其中包括)在於向受益人就彼等對公司及其附屬公司所作出貢獻提供激勵或報酬。由於市場波動及COVID-19疫情持續不斷的事態發展,故公司已一直考慮對授出購股權作出適當調整及改動以儘量提高激勵的程度。因此,本公司在承授人及相關受益人的同意下,根據公司與承授人於2022年5月10日訂立的註銷契據及由各相關受益人作出的同意契據無償註銷全部購股權。公司將不時繼續開拓不同的激勵計劃及獎勵。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.